文献速递类风湿关节炎

组织损伤与类风湿关节炎滑膜成纤维细胞中肽基甘氨酸α-酰胺化单加氧酶低活性遗传相关

Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha-Amidating Monooxygenase Activity in Synovial Fibroblasts.
PubMed 文献 · Arthritis Rheumatol · 2026-04-14

研究探讨rs26232 C等位基因与类风湿关节炎(RA)严重程度的生物学机制。rs26232 C与多种组织包括RA滑膜成纤维细胞(RASFs)中肽基甘氨酸α-酰胺化单加氧酶(PAM)低表达相关。PAM抑制增强RASFs组织损伤活性,而酰胺化肽ADM和PAMP具有抗炎作用,抑制酰胺化使巨噬细胞向促炎表型极化,解释rs26232 C与RA严重程度的关联。

要点

  • rs26232 C等位基因与RASFs中PAM低表达相关。
  • PAM抑制增强RASFs体外侵袭性等组织损伤活性。
  • ADM和PAMP抑制IL-6和IL-8并减少RASFs侵袭性。

核心结论

  • 遗传决定的PAM低活性通过减少ADM和PAMP介导的抗炎及组织损伤活动,解释rs26232 C与RA严重程度的关联。

研究设计与样本

  • 比较rs26232不同基因型间周围基因表达,利用公共数据库关联表达与RA炎症及单细胞滑膜分布。
  • 使用小干扰RNA和药理学试剂抑制基因表达和活性,体外检测对RASFs特征的影响。
  • 通过质谱和酶联免疫吸附测定表征滑膜成纤维细胞酰胺化分泌组。
  • 利用RASF-巨噬细胞共培养模型确定酰胺化肽对巨噬细胞极性的影响。

主要发现

  • rs26232 C与包括RASFs在内的多种组织中PAM低表达相关。
  • 滑膜PAM在RASFs中高表达而非免疫细胞,其水平与滑膜和全身炎症水平呈负相关。
  • 抑制RASFs中PAM增加体外侵袭性等组织损伤活性。
  • RASFs分泌最丰富的酰胺化肽为肾上腺髓质素(ADM)和pro-ADM N端肽(PAMP)。
  • ADM或PAMP孵育RASFs抑制白细胞介素-6(IL-6)和IL-8,增加转化生长因子β产生,减少体外侵袭性。

临床怎么用

  • rs26232 C等位基因携带者可能因PAM低表达而具有更高RA严重程度风险。
  • 靶向PAM或其酰胺化肽产物ADM和PAMP可能成为减轻RA组织损伤的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Both susceptibility to, and severity of, rheumatoid arthritis (RA) is associated with the rs26232 C allele. Our primary aim was to identify the biologic mechanism underlying this association. METHODS: Expression of surrounding genes was compared among rs26232 genotypes. Publicly available databases were used to correlate expression with RA inflammation and single-cell synovial distribution. Inhibition of gene expression and activity was achieved using small interfering RNA and a pharmacology agent and effects on RA synovial fibroblasts (RASFs) characteristics in vitro were assayed. The amidated secretome of synovial fibroblasts were characterized by mass spectrometry and enzyme-linked immunosorbent assay. Effects of amidated peptides on macrophage polarity were determined using an RASF-macrophage coculture module. RESULTS: rs26232 C is associated with low expression of peptidylglycine alpha-amidating monooxygenase (PAM) in multiple tissues including RASFs. Synovial PAM is highly expressed in RASFs but not immune cells, and levels are inversely correlated with synovial and systemic levels of inflammation. Inhibition of PAM in RASFs increased tissue-damaging activities such as invasiveness in vitro. The most abundant amidated peptides secreted by RASFs were adrenomedullin (ADM) and pro-ADM N-terminal peptide (PAMP). Incubation of RASFs with either peptide inhibited interleukin-6 (IL-6) and IL-8, increased transforming growth factor β production, and reduced invasiveness in vitro. Inhibition of amidation in an RASF-macrophage coculture model skewed the macrophages to proinflammatory MerTK- phenotypes. CONCLUSION: Genetically determined low PAM reduces the anti-inflammatory and tissue-damaging activities of ADM and PAMP mediated by macrophages and RASFs, explaining the association of rs26232 C with RA severity.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Sheridan KJ, Dorris ER, Pimenta MI, et al. Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha-Amidating Monooxygenase Activity in Synovial Fibroblasts. Arthritis Rheumatol. 2026. PMID: 41797318. doi:10.1002/art.70123

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。